111
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Chronic Progression of Lung Cancer Recurrence After Surgery: Warning Role of Postoperative Pneumonia

, , , , , , & show all
Pages 7387-7398 | Published online: 24 Sep 2021

References

  • Lou F, Huang J, Sima C, Dycoco J, Rusch V, Bach P. Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. The Journal of thoracic and cardiovascular surgery. 2013;145(1):75–81.
  • DeslauriersJ, GinsbergRJ, PiantadosiS, FournierB. Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer. Chest. 1994;106(6):329S–330S. doi:10.1378/chest.106.6_Supplement.329S7988256
  • MitásL, HorváthT, SobotkaM, GarajováB, VomelaJ. [Complications in patients undergoing pulmonary oncological surgery]. Rozhledy v Chirurgii. 2010;89(2):113–117. Czech.20429332
  • SimonsenDF, SøgaardM, BoziI, HorsburghCR, ThomsenRW. Risk factors for postoperative pneumonia after lung cancer surgery and impact of pneumonia on survival. Respir Med. 2015;109(10):1340–1346. doi:10.1016/j.rmed.2015.07.00826209227
  • HöffkenG, NiedermanMS. Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest. 2002;122(6):2183–2196. doi:10.1378/chest.122.6.218312475862
  • RosolemMM, RabelloL, LisboaT, et al. Critically ill patients with cancer and sepsis: clinical course and prognostic factors. J Crit Care. 2012;27(3):301. doi:10.1016/j.jcrc.2011.06.01421855281
  • FarjahF, BackhusL, ChengA. Failure to rescue and pulmonary resection for lung cancer. J Thorac Cardiovasc Surg. 2015;149(5):1365–1373.e1363. doi:10.1016/j.jtcvs.2015.01.06325791948
  • SametJM, Avila-TangE, BoffettaP, et al. Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin Cancer Res. 2009;15(18):5626–5645. doi:10.1158/1078-0432.CCR-09-037619755391
  • WakeleeHA, ChangET, GomezSL, et al. Lung cancer incidence in never smokers. J Clin Oncol. 2007;25(5):472–478. doi:10.1200/JCO.2006.07.298317290054
  • LoYL, TsaiYH, ChangGC, et al. Risk factors for primary lung cancer among never smokers by gender in a matched case-control study. Cancer Causes Control. 2013;24(3):567–576. doi:10.1007/s10552-012-9994-x22729933
  • WuFZ, HuangYL, WuC, et al. Assessment of selection criteria for low-dose lung screening CT among Asian Ethnic Groups in Taiwan: from mass screening to specific risk-based screening for non-smoker lung cancer. Clin Lung Cancer. 2016;17(5):e45–e56. doi:10.1016/j.cllc.2016.03.00427133540
  • HsuHT, TangEK, WuMT, et al. Modified lung-RADS improves performance of screening LDCT in a population with high prevalence of non–smoking-related lung cancer. Acad Radiol. 2018;25(10):1240–1251. doi:10.1016/j.acra.2018.01.01229530488
  • LouF, HuangJ, SimaCS, DycocoJ, RuschV, BachPB. Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. J Thorac Cardiovasc Surg. 2013;145(1):75–82. doi:10.1016/j.jtcvs.2012.09.03023127371
  • BuggeAS, LundMB, ValbergM, BrustugunOT, SolbergS, KongerudJ. Cause-specific death after surgical resection for early-stage non-small-cell lung cancer. Eur J Cardio Thorac Surg. 2018;53(1):221–227.
  • RaduDM, JauréguyF, SeguinA, et al. Postoperative pneumonia after major pulmonary resections: an unsolved problem in thoracic surgery. Ann Thorac Surg. 2007;84(5):1669–1673. doi:10.1016/j.athoracsur.2007.05.05917954082
  • ChaftJE, RimnerA, WederW, AzzoliCG, CasconeT. Evolution of systemic therapy for stages I-III non-metastatic non-small-cell lung cancer. Nat Rev Clin Oncol. 2021;18:547–557.33911215
  • ShermanRE, AndersonSA, PanGD, et al. Real-world evidence - what is it and what can it tell us?N Engl J Med. 2016;375(23):2293–2297. doi:10.1056/NEJMsb160921627959688
  • KhooJK, BarnesH, KeyS, GlaspoleIN, ÖstörJ. Pulmonary adverse events of small molecule JAK inhibitors in autoimmune disease: systematic review and meta-analysis. Rheumatology. 2020;59(9):2217–2225. doi:10.1093/rheumatology/keaa11732406509
  • FedorD, JohnsonWR, SinghalS. Local recurrence following lung cancer surgery: incidence, risk factors, and outcomes. Surg Oncol. 2013;22(3):156–161. doi:10.1016/j.suronc.2013.04.00223702313
  • WatkinsRR, LemonovichTL. Diagnosis and management of community-acquired pneumonia in adults. Am Fam Physician. 2011;83(11):1299–1306.21661712
  • MarrieTJ. Community-acquired pneumonia. Clin Infect Dis. 1994;18(4):501–513. doi:10.1093/clinids/18.4.5018038304
  • KobayashiS, KarubeY, MatsumuraY, NishihiraM, ChidaM. Inflammatory risk factors for early recurrence of non-small cell lung cancer within one year following curative resection. World J Surg. 2020;44(10):3510–3521. doi:10.1007/s00268-020-05612-032462215
  • SarıçamM. Efficacy of preoperative white blood cell count and lymphocyte/monocyte ratio in predicting post-lobectomy pneumonia. Turk J Thorac Cardiovasc Surg. 2021;29(1):84–91. doi:10.5606/tgkdc.dergisi.2021.19950
  • LeoF, PelosiG, SonzogniA, ChilosiM, BonomoG, SpaggiariL. Structural lung damage after chemotherapy: fact or fiction?Lung Cancer. 2010;67(3):306–310. doi:10.1016/j.lungcan.2009.04.01319477548
  • HigenbottamT, KuwanoK, NemeryB, FujitaY. Understanding the mechanisms of drug-associated interstitial lung disease. Br J Cancer. 2004;91(S2):S31–37. doi:10.1038/sj.bjc.660206515340376
  • Mahmutovic PerssonI, von WachenfeldtK, WatertonJ, OlssonL; On Behalf Of The Tristan Consortium. Imaging biomarkers in animal models of drug-induced lung injury: a Systematic Review. J Clin Med. 2020;10(1):107. doi:10.3390/jcm10010107
  • GemmaA, KusumotoM, KuriharaY, et al. Interstitial lung disease onset and its risk factors in Japanese patients with ALK-Positive NSCLC after treatment with crizotinib. J Thorac Oncol. 2019;14(4):672–682. doi:10.1016/j.jtho.2018.11.02230521972
  • SharmaSV, BellDW, SettlemanJ, HaberDA. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer. 2007;7(3):169–181.17318210
  • ZhongW, WangQ, MaoW, et al. Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC: final overall survival analysis of CTONG1104 Phase III Trial. J Clin Oncol. 2021;39(7):713–722. doi:10.1200/JCO.20.0182033332190
  • AndersonGP, BozinovskiS. Acquired somatic mutations in the molecular pathogenesis of COPD. Trends Pharmacol Sci. 2003;24(2):71–76. doi:10.1016/S0165-6147(02)00052-412559770
  • LiuY, GaoW, ZhangD. Effects of cigarette smoke extract on A549 cells and human lung fibroblasts treated with transforming growth factor-β1 in a coculture system. Clin Exp Med. 2010;10(3):159–167. doi:10.1007/s10238-009-0081-x19924381
  • VeljkovicE, JiricnyJ, MenigattiM, RehrauerH, HanW. Chronic exposure to cigarette smoke condensate in vitro induces epithelial to mesenchymal transition-like changes in human bronchial epithelial cells, BEAS-2B - ScienceDirect. Toxicol Vitro. 2011;25(2):446–453. doi:10.1016/j.tiv.2010.11.011
  • MilaraJ, CortijoJ. Tobacco, inflammation, and respiratory tract cancer. Curr Pharm Des. 2012;18(26):3901–3938. doi:10.2174/13816121280208374322632749
  • kudelaK, MatsumuraM, AraiH, WooT. The nonsmokers' and smokers' pathways in lung adenocarcinoma: Histological progression and molecular bases. Cancer science. 2021.
  • YatabeY. EGFR mutations and the terminal respiratory unit. Cancer Metastasis Rev. 2010;29(1):23. doi:10.1007/s10555-010-9205-820135199
  • KotlyarovEV, RukosuyevAA. Long-term results and patterns of disease recurrence after radical operations for lung cancer. J Thorac Cardiovasc Surg. 1991;102(1):24–28. doi:10.1016/S0022-5223(19)36580-82072725
  • HashimotoT. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases. Cancer Res. 2000;60:6472–6478.11103815
  • PasslickB, IzbickiJR, KubuschokB, ThetterO, PantelK. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis. Ann Thorac Surg. 1996;61(1):177. doi:10.1016/0003-4975(95)01012-28561549
  • LeungE, XueA, WangY, RougerieP, SharmaVP. Blood vessel endothelium-directed tumor cell streaming in breast tumors requires the HGF/C-Met signaling pathway. Oncogene. 2017;36(19):2680–2692. doi:10.1038/onc.2016.42127893712
  • McdonaldB, SpicerJ, GiannaisB, FallavollitaL, BrodtP, FerriLE. Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms. Int J Cancer. 2010;125(6):1298–1305.
  • KateMT, HoflandLJ, GrevensteinW, KoetsveldP, JeekelJ, EijckC. Influence of proinflammatory cytokines on the adhesion of human colon carcinoma cells to lung microvascular endothelium. Int J Cancer. 2004;112(6):943–950. doi:10.1002/ijc.2050615386356
  • KitamuraT, QianBZ, PollardJW. Immune cell promotion of metastasis. Nat Rev Immunol. 2015;15(2):73–86. doi:10.1038/nri378925614318
  • HanahanD, WeinbergRA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi:10.1016/j.cell.2011.02.01321376230